Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 7/20 | 0.50 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.48 |
| ▸ | SELE | P16581 | 4/20 | 0.47 |
| ▸ | SELL | P14151 | 2/20 | 0.43 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16342337 | 1.00 | MAG (0.50) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL25446563 | 1.00 | MAG (0.50) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL12196998 | 1.00 | MAG (0.50) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL16187872 | 1.00 | MAG (0.50) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL12197077 | 0.95 | MAG (0.48) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL4119673 | 0.95 | MAG (0.48) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL17195861 | 0.95 | MAG (0.48) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL15849102 | 0.95 | MAG (0.48) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL16232780 | 0.95 | MAG (0.48) | MAGSIGLEC7SELESELLSELP | |
| SCHEMBL16312032 | 0.95 | MAG (0.48) | MAGSIGLEC7SELESELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9937264-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9802996-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9708413-B2 | Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof | GLYTECH, INC. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-9441024-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2016-09-13 | — | — | US | disclosed |
| US-9422357-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2016-08-23 | — | — | US | disclosed |
| US-20150306235-A1 | SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME | GLYTECH INC (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | GLYTECH INC (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20140369964-A1 | GLYCOSYLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | GLYTECH, INC. (JP) | 2014-12-18 | — | — | US | disclosed |
| US-20140336116-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GLYTECH, INC. (JP) | 2014-11-13 | — | — | US | disclosed |
| US-20140315800-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GLYTECH, INC. (JP) | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR4, SSTR3 | MAG 784/4885SIGLEC7 100/4885SELE 428/4885 |
| US-20150299337-A1 | GLYCOSYLATED LINKER, COMPOUND CONTAINING GLYCOSYLATED LINKER MOIETY AND PHYSIOLOGICALLY ACTIVE SUBSTANCE MOIETY OR SALT THEREOF, AND METHODS FOR PRODUCING SAID U OR SALT THEREOF | CD44, CSGALNACT1, UGGT1 | MAG 644/4885SIGLEC7 8/4885SELE 148/4885 |
| US-20140336116-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GIPR, SSTR4, SSTR5 | MAG 778/4885SIGLEC7 104/4885SELE 430/4885 |
| US-20150306235-A1 | SUGAR CHAIN-ATTACHED LINKER, COMPOUND CONTAINING SUGAR CHAIN-ATTACHED LINKER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND METHOD FOR PRODUCING SAME | SI, ENGASE, DNPEP | MAG 1177/4885SIGLEC7 29/4885SELE 219/4885 |
| US-20160368961-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR3, SSTR4 | MAG 766/4885SIGLEC7 92/4885SELE 440/4885 |
| US-20140315800-A1 | Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide | GIPR, SSTR3, SSTR4 | MAG 766/4885SIGLEC7 92/4885SELE 440/4885 |
| US-20140369964-A1 | GLYCOSYLATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | IFNG, IFNAR1, IAPP | MAG 1226/4885SIGLEC7 20/4885SELE 1381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.